4//SEC Filing
Kunin Audrey 4
Accession 0001437749-22-022646
CIK 0001389545other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:24 PM ET
Size
4.9 KB
Accession
0001437749-22-022646
Insider Transaction Report
Form 4
Kunin Audrey
Chief Product Officer
Transactions
- Sale
Common Stock
2022-09-14$0.16/sh−291,368$46,094→ 208,632 total(indirect: See footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001738781
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:24 PM ET
- Size
- 4.9 KB